Procter & Gamble Health Financial Statements

Procter & Gamble Health (PGHL) reported revenue of ₹9.45B in FY2025 with net income of ₹2.34B. Total assets stood at ₹7.94B and free cash flow was ₹1.60B.

Procter & Gamble Health Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		10.27B	11.28B	12.48B	11.67B	9.45B
Cost of Rev. Cost of Revenue		-3.15B	-3.40B	-3.62B	-3.31B	-2.63B
Gross Profit		7.12B	7.88B	8.86B	8.36B	6.82B
SGA Sales, General & Admin		-4.48B	-5.06B	-5.44B	-5.15B	-3.53B
Op. Income Operating Income		2.34B	2.54B	3.15B	2.94B	3.12B
PBT Profit Before Tax		2.33B	2.53B	3.14B	2.73B	3.12B
Net Income		1.77B	1.93B	2.29B	2.01B	2.34B
Dil. Shares Diluted Shares		16.60M	16.60M	16.60M	16.60M	16.60M
Diluted EPS		106.51	116.00	138.23	121.07	141.22

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Procter & Gamble Health's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Procter & Gamble Health Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		7.27B	6.08B	7.96B	5.24B	5.26B
Non-curr. assets Total non-current assets		2.59B	2.80B	3.05B	2.70B	2.68B
Total assets		9.86B	8.88B	11.01B	7.94B	7.94B
Curr. liabilities Total current liabilities		2.39B	2.32B	3.04B	2.19B	2.15B
Non-curr. liab. Total non-current liabilities		434.80M	397.30M	464.00M	372.10M	419.30M
Total liabilities		2.82B	2.72B	3.50B	2.56B	2.57B
Total equity		7.04B	6.16B	7.51B	5.38B	5.37B
Total liab. & eq. Total liabilities & equity		9.86B	8.88B	11.01B	7.94B	7.94B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Procter & Gamble Health's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Procter & Gamble Health Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		2.33B	2.53B	3.14B	2.73B	3.12B
Operating CF Cash flow Operating Activities		2.47B	1.70B	2.36B	2.28B	1.69B
Capex Investments in PPE		-525.80M	-379.20M	-424.80M	-217.30M	-85.60M
Investing CF Cash flow Investing Activities		-322.70M	-255.40M	-215.00M	-68.70M	95.90M
Dividend Paid		-3.82B	-2.84B	-937.90M	-4.15B	-2.32B
Financing CF Cash flow Financing Activities		-3.87B	-2.89B	-984.70M	-4.18B	-2.35B
Cash (start) Cash at beginning of period		6.36B	4.64B	3.19B	4.35B	2.39B
Cash (end) Cash at end of period		4.64B	3.19B	4.35B	2.39B	1.82B
FCF Free Cash Flow		1.95B	1.32B	1.94B	2.07B	1.60B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Procter & Gamble Health's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025